ZBH profile · all as-reported value updates
ZIMMER BIOMET HOLDINGS, INC. (ZBH) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Operating income | 2020 | -87,800,000 | 83,100,000 | 170,900,000 | +194.65% | revised comparative figure | 0001564590-21-007163 0000950170-23-004264 | 3 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2021 | 478,500,000 | 378,100,000 | -100,400,000 | -20.98% | revised comparative figure | 0001564590-22-007160 0000950170-23-004264 | 2 filed observations examined for this concept and period. |
| Capital expenditures | 2021 | 172,000,000 | 143,600,000 | -28,400,000 | -16.51% | revised comparative figure | 0001564590-22-007160 0000950170-24-019353 | 3 filed observations examined for this concept and period. |
| Revenue | 2021 | 7,836,200,000 | 6,827,300,000 | -1,008,900,000 | -12.87% | revised comparative figure | 0001564590-22-007160 0000950170-24-019353 | 3 filed observations examined for this concept and period. |
| Revenue | 2020 | 7,024,500,000 | 6,127,500,000 | -897,000,000 | -12.77% | revised comparative figure | 0001564590-21-007163 0000950170-23-004264 | 3 filed observations examined for this concept and period. |
| Operating income | 2021 | 780,100,000 | 860,300,000 | 80,200,000 | +9.32% | revised comparative figure | 0001564590-22-007160 0000950170-24-019353 | 3 filed observations examined for this concept and period. |
| Capital expenditures | 2020 | 117,500,000 | 111,900,000 | -5,600,000 | -4.77% | revised comparative figure | 0001564590-21-007163 0000950170-23-004264 | 3 filed observations examined for this concept and period. |
| Operating income | 2017 | 808,200,000 | 799,300,000 | -8,900,000 | -1.10% | revised comparative figure | 0001564590-18-003549 0001564590-20-005657 | 3 filed observations examined for this concept and period. |